FDA medical device cybersecurity

Cybersecurity built into your software, and documented for your FDA submission.

We work with your dev team on threat modeling and risk analysis, and prepare the premarket documentation the U.S. Food and Drug Administration (FDA) describes in its February 3, 2026 cybersecurity guidance.

In short

What does FDA medical device cybersecurity work include?

It includes threat modeling, cybersecurity risk analysis, a Software Bill of Materials (SBOM), and the premarket cybersecurity documentation FDA describes in "Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions" (February 3, 2026).

MedDev Solutions prepares that documentation with your dev team, including the evidence from your security testing, and keeps it current after release. Our work is designed to support compliance with IEC 81001-5-1.

The problem

Security added at the end doesn't trace back to the design.

FDA recommends threat modeling throughout the design process, not once, and traceability between your threat model, cybersecurity risk assessment, Software Bill of Materials (SBOM), and testing documentation.

The handoffArchitecture change to submission

Security beside development
  • Security runs beside your development process.
  • Traceability between threat model, risk, SBOM, and tests breaks.
  • The documentation gets rebuilt in the month before submission.
Security inside development
  • When your architecture changes, the threat model changes with it.
  • Security requirements become backlog items your developers build and test.
  • Each test result traces back to a threat and a risk.
  • Your regulatory team sees the documentation grow with the product.

How we work with your team

Who does what, from design to release?

You want a team that works inside yours, not another vendor to manage. FDA sets the expectation, we prepare the evidence, and your team stays in charge.

  1. 01What FDA expects

    Threat modeling throughout design, and evidence that traces.

    FDA's February 3, 2026 cybersecurity guidance recommends threat modeling throughout the design process, with traceability between your threat model, risk assessment, SBOM, and testing documentation, kept current after release.

  2. 02What we prepare

    The threat model, the risk analysis, and the premarket documentation.

    We work with your dev team on threat modeling and risk analysis, document the evidence from your security testing, and prepare the premarket cybersecurity documentation. After release, we keep it current.

  3. 03What your team owns

    Your engineers know the system and stay in charge of it.

    Your developers get security requirements they can build and test. Your company remains the manufacturer and keeps responsibility for its design controls and submission.

What we deliver

What do we deliver, for the device and the organization?

FDA reviews the cybersecurity evidence for your device. FDA's guidance says manufacturers should update their security risk management documentation as new threats and vulnerabilities appear, including after release. We prepare both, for software and embedded firmware.

For your device software

The evidence your premarket submission needs, traced from threat to risk to test, and written in the structure FDA's guidance recommends.

  • Threat modeling throughout design, updated as your architecture changes
  • Cybersecurity risk analysis for your device software
  • Your security testing evidence documented, with findings traced back to threats and risks
  • Premarket cybersecurity documentation, including the SBOM and, for each third-party software component, its level of support and end-of-support date
  • Firmware in scope as embedded software

For your quality system and process

The process that keeps your security evidence current from first design review through release and after it. Designed to support compliance with IEC 81001-5-1.

  • Gap analysis against FDA's February 3, 2026 cybersecurity guidance and IEC 81001-5-1
  • Threat modeling and Secure Software Development Lifecycle (SSDLC) set up in your process
  • Security risk documentation kept current after release, plus post-market cybersecurity support
  • Readiness programs for ISO/IEC 27001 certification, Health Insurance Portability and Accountability Act (HIPAA), and System and Organization Controls (SOC) 2 examinations (issued by your certified public accountant (CPA) firm)

How an engagement runs

How does an engagement run?

In five phases, from gap analysis to post-market updates. Timing depends on your software and where you start. We scope each phase with you on the first call.

  1. Assess

    Gap analysis against FDA's February 3, 2026 cybersecurity guidance and IEC 81001-5-1. You get a list of gaps, ranked by what your submission needs first.

  2. Model

    Threat model and cybersecurity risk analysis of your architecture, with security requirements written into your backlog and an SSDLC set up.

  3. Trace

    The evidence from your security testing documented, with every finding traced to a threat, a risk, and a fix.

  4. Document

    Premarket cybersecurity documentation, built with your regulatory team: threat model, risk assessment, SBOM, and test evidence that trace to each other.

  5. Maintain

    After release, we update your security risk documentation as new threats and vulnerabilities appear, so you can assess their impact on fielded devices quickly.

Questions we get

Cybersecurity FAQ

Answer

MedDev Solutions

We add the medical device part your engineers don't usually cover: threat modeling and risk analysis in the structure FDA's guidance recommends, the evidence from your security testing traced to those risks, and premarket documentation that matches. Your engineers know the system and stay in charge of it. Your company remains the manufacturer and keeps responsibility for its design controls and submission.

MedDev Solutions

FDA's "Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions," issued February 3, 2026, and IEC 81001-5-1:2021 with Interpretation Sheet 1 (2025). Our work is designed to support compliance with IEC 81001-5-1.

MedDev Solutions

No, it isn't too late to start. FDA recommends threat modeling throughout the design process, and your design will keep changing. We model the architecture you have now, trace threats to risks and tests, and keep the model current as your software changes.

MedDev Solutions

No. FDA says manufacturers should update security risk documentation as new threats and vulnerabilities appear, during development and after release. We keep that documentation current and support your post-market cybersecurity work.

MedDev Solutions

No. We cover software, including embedded firmware. We don't do hardware design, electronics, or hardware testing. Tell us your architecture and we'll scope the software side.

Something else? Ask us directly on a 30-minute call

Next step

Show us your architecture.We'll talk through where to start.

In 30 minutes, we'll walk through your software, your submission plan, and FDA's current cybersecurity guidance. We'll suggest a first step.